With an income increase of 374.38% in the fourth quarter 2025, year on year to cumulative value of $1,299 million, and with 3,029 employees, Genmab A's income per employee grew on trailing twelve month basis to $ 428,854. The income per employee at Genmab A' was above the company average.
The Healthcare sector has seen employees of 39 other companies achieving higher income per employee. While Genmab A's total ranking has deteriorated compared to the previous quarter from to 536.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GMAB Net Income per Employee	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) II. Quarter
Y / Y Net Income Change	374.38 %	-	24.16 %	-	-59.31 %
Net Income per Employee (TTM) $	428,854	177,947	242,365	220,779	237,150
GMAB's Total Ranking	# 536	#	#	#	#
Seq. Net Income Change	-	-	-	-	4.04 %

GMAB Company Profile >> Back to GMAB Efficiency Comparisons >> Compare GMAB Net Income per Employee to its Competitors

GMAB Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 40
Healthcare Sector	# 66
Overall Market	# 536

Net Income per Employee Statistics
High	Average	Low
$ 374,051	$ 258,483	$ 155,299
(Dec 31 2024)		(Dec 31 2021)

Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector	Income per Employee	Income 12 month ending Dec 31 2025	Number of Employees Dec 31 2025
Halozyme Therapeutics Inc	749,146.57	$ 316.889 Million	423
Traws Pharma inc	731,294.12	$ 12.432 Million	17
Krystal Biotech Inc	694,342.37	$ 204.831 Million	295
Ptc Therapeutics inc	688,843.59	$ 682.644 Million	991
Elite Pharmaceuticals Inc	667,834.38	$ 43.409 Million	65
Black Hawk Acquisition Corporation	664,778.50	$ 1.330 Million	2
Illumina Inc	664,062.50	$ 850.000 Million	1,280
Biocryst Pharmaceuticals Inc	606,577.01	$ 263.861 Million	435
Amgen Inc	593,153.85	$ 7,711.000 Million	13,000
Novavax inc	587,853.14	$ 440.302 Million	749
Hutchmed china Limited	586,835.90	$ 457.732 Million	780
Harmony Biosciences Holdings inc	541,593.86	$ 158.687 Million	293
Entera Bio Ltd	519,954.55	$ 11.439 Million	22
Scisparc Ltd	502,560.00	$ 12.564 Million	25
Gilead Sciences Inc	500,588.24	$ 8,510.000 Million	17,000
Acadia Pharmaceuticals Inc	489,974.94	$ 391.000 Million	798
Omada Health Inc	476,262.01	$ 436.256 Million	916
Siga Technologies Inc	475,084.55	$ 23.279 Million	49
Incyte Corporation	452,408.58	$ 1,286.650 Million	2,844
Eli Lilly And Company	412,800.00	$ 20,640.000 Million	50,000
Sanuwave Health Inc	410,381.82	$ 22.571 Million	55
Spero Therapeutics Inc	342,880.00	$ 8.572 Million	25
Arrowhead Pharmaceuticals Inc	328,514.77	$ 233.574 Million	711
Alpha Tau Medical Ltd	327,900.00	$ 42.627 Million	130
Genmab A	317,926.71	$ 963.000 Million	3,029
Abeona Therapeutics Inc	314,969.03	$ 71.183 Million	226
Regeneron Pharmaceuticals Inc	292,336.15	$ 4,504.900 Million	15,410
Icecure Medical Ltd	273,763.64	$ 15.057 Million	55
Dariohealth Corp	252,812.12	$ 41.714 Million	165
Vaxart Inc	251,184.62	$ 16.327 Million	65

Date modified: 2026-07-07T11:25:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.